Find a Clinical Trial

Find cancer trials

Search by keyword, study number, or principal investigator.

You searched for:

Manchester Bedford

24 search results

CFMED

The Impact of Sharing Audio Recorded Clinic Visits on Self-Management in Older Adults: A Multi-site Trial

Location: Manchester

Medicine-General Internal Medicine

Comparing Healthcare visit Recording and Open Notes to Improve Chronic iLlness care Experience in older adults (the CHRONICLE Trial)

Location: Bedford, Manchester, Lebanon

Medicine-Pulmonology

A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)

Location: Manchester

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis

Location: Manchester

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 in Healthy Adult Subjects and in Adults with Cystic Fibrosis

Location: Manchester

A Phase 2 Study of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 in Subjects with Cystic Fibrosis who are Heterozygous for the F508del Mutation

Location: Manchester

A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis

Location: Manchester

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis

Location: Lebanon, Manchester

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation

Location: Manchester

A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation

Location: Manchester

A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)

Location: Manchester

A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Location: Manchester

A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects with Cystic Fibrosis of Chronic Pancreatitis Treated with Creon (Pancrelipase) with an Alternate Source of Active Pharmaceutical Ingredient

Location: Manchester

An Observational Long-Term Safety Surveillance of Participants from Corbus Sponsored Lenabasum Pivotal Clinical Trials

Location: Manchester

Cystic Fibrosis Foundation Patient Registry

Location: Bedford, Manchester, Lebanon

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis

Location: Manchester, Lebanon

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis

Location: Lebanon, Manchester

The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes

Location: Manchester, Lebanon

The Effects Of Systemic Anti-Pseudomonal Therapy On Fungal Load In Cystic Fibrosis

Location: Bedford, Lebanon

Pediatrics/Adolescent Medicine-General Pediatrics

The Developing Infant: Mapping the Microbiome in Health and in Disease

Location: Bedford, Manchester, Lebanon

Using patient data to transform care and improve outcomes for children, adolescents, and young adults with Inflammatory Bowel Disease

Location: Manchester, Lebanon

Vitamin D Oral Replacement in Asthma

Location: Manchester

Pediatrics/Adolescent Medicine-Pediatric Pulmonology

A Prospective Observational Study in Cystic Fibrosis Patients With Chronic Respiratory Pseudomonas Aeruginosa Infection Treated With TOBI Podhaler (Tobramycin Inhalation Powder) or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

Location: Manchester

Psychiatry

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

Location: Manchester

Looking for cancer trials? Visit our cancer site.